BioAge Labs
BIOA9.8258.68% ( +0.785 )
BioAge Labs (BIOA)
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform...
- Open
- 9.520
- High
- 9.950
- Low
- 9.180
- Prev. Close
- 9.040
- Volume
- 876.14K
- Turnover
- 8.41M
- Avg Price
- 9.600
- Bid/Ask Ratio
- --
- Amplitude
- 8.52%
- 52wk High
- 25.955
- Volume Ratio
- 8.15
- Turnover Ratio
- 2.51%
BioAge Labs Analyst Rating
View MoreForecast & Rating
Jul 31, 2026Price forecast
$39.88305.85%
Forecast & RatingBuy
9analysts
- Strong buy55.56%
- Buy22.22%
- Hold22.22%
- Sell0.00%
- Strong sell0.00%
News
- Price Alert · 5 hours ago
Pre-market hot trades in US stocks: Livewire pre-market down 8.52%; BioAge Labs pre-market up 8.41%
- Tip Ranks · 2 days ago, 01:55 PM
Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)
- Tip Ranks · 2 days ago, 01:36 PM
BioAge Therapeutics: Buy Rating Maintained Despite Cut in Price Target to $21 on Refined ASCVD and Ocular Program Assumptions
- Tip Ranks · 2 days ago, 01:36 PM
Buy Rating Reaffirmed on BioAge: Sell-Off Seen as Overdone Amid Validated NLRP3 Platform and Triple-Digit Upside Potential
- businessinsider · 2 days ago, 01:16 PM
Monte Rosa, BioAge plunge as Novo’s setback casts a shadow over pipeline
- benzinga_article · 2 days ago, 12:24 PM
Why Is BioAge Labs Stock Sinking Friday?
